Hint mode is switched on Switch off

Genfit, American depositary receipt (ADR)
GNFT, US3722791098

Add a stock to WL
Choose all Reset all
Genfit, сountry — France
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
No data
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest quotes

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Issuer

Profile
GENFIT is a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions to address high unmet patient needs in metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology.
  • Issuer
  • Full borrower / issuer name
    Genfit SA
  • Industry
    Pharmaceutical Preparation and Biotechnology

Placement data

  • Placement type
    IPO | Finished
  • Subscription type
    Open
  • Placement exchange
    NASDAQ
  • Ticker
    GNFT
  • Placement
    27.03.2019
  • Lock up period
    180
  • Number of papers
    6,150,000
  • Volume of raised funds
    124.97 mln USD
  • Placement share
    16.26%
  • Final placement price
    20.32 USD
  • Price change since placement date
    -100%
  • By capitalization
    768.79 mln USD

IFRS/US GAAP reports

2024
IV q eng
2023
IV q eng
2022
IV q eng
2021
IV q eng
2020
IV q eng
2019
IV q eng
Show all Hide

Indicators

News

23/09/2025 GENFIT SA (NASDAQ:GNFT) Earnings Report Highlights
17/02/2025 Genfit Seeks Bondholder Consent for Amended Repurchase Proposal Terms
All organization news

Other stocks and deposit receipts

Holders

Industry Leaders

Registration is required to get access.